GRM3 and neoplasm: GRM3 gene expression was significantly lower in tumour, late‐stage, and high‐grade tissues (P < 0.001, Figure 3A‐C), and low expression of GRM3 was associated with poor OS in patients with RCC (P = 0.004, Figure 3D).